Exact Mass: 604.3445

[(S)-1-Carboxy-2-phenyl-ethyl]-carbamoyl-Arg-Val-Arg-aldehyde

C27H44N10O6 (604.3445)

Dilazep

C31H44N2O10 (604.2996)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Telinavir

C33H44N6O5 (604.3373)

PA(10:0/18:1(12Z)-O(9S,10R))

C31H57O9P (604.374)

PA(10:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-O(9S,10R)/10:0)

C31H57O9P (604.374)

PA(18:1(12Z)-O(9S,10R)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/10:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/18:1(9Z)-O(12,13))

C31H57O9P (604.374)

PA(10:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(9Z)-O(12,13)/10:0)

C31H57O9P (604.374)

PA(18:1(9Z)-O(12,13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/10:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Belamide A

C35H48N4O5 (604.3625)

Periplocoside M

C34H52O9 (604.3611)

Laurenmariannol

C30H53BrO7 (604.2974)

thyrsiferol

C30H53BrO7 (604.2974)

Sublanceoside B1

C33H48O10 (604.3247)

luvungin D

C34H52O9 (604.3611)

3beta-p-Hydroxybenzoyldehydrotumulosic acid

C38H52O6 (604.3764)

Caseamembrin D

C33H48O10 (604.3247)

Tiacumicin A

C34H52O9 (604.3611)

Mezzettiaside 9

C30H52O12 (604.3459)

Luvungin G

C34H52O9 (604.3611)

Viridominic acid B

C33H48O10 (604.3247)

KS 501

C33H48O10 (604.3247)

Antipain

C27H44N10O6 (604.3445)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

aeruginosin 298-A

C30H48N6O7 (604.3584)

HMR1171

C35H48N4O3S (604.3447)

methyl-ent-15alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate|methyl-ent-15alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate

C33H48O10 (604.3247)

C33H48O10

C33H48O10 (604.3247)

(5alpha,7alpha,13alpha17alpha,20S,23R,24R)-21,25-epoxy-23,24-dihydroxy-4,4,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol C

C38H52O6 (604.3764)

(3R,5aR,5bR,6R,7S,9S,11aS,12R,13bS)-12-(acetyloxy)icosahydro-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|11alpha-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,6beta-diol|cavalerol B

C38H52O6 (604.3764)

dichrostachine O

C36H44O8 (604.3036)

14-acetoxy-3,14-dihydroimplexin

C33H48O10 (604.3247)

(3R,5aR,5bR,6R,7S,9S,11aR,12S,13bS)-7-(acetyloxy)icosahydro-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|6beta-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,11beta-diol|cavalerol G

C38H52O6 (604.3764)

pedunculol

C38H52O6 (604.3764)

Xanthochymol

C38H52O6 (604.3764)

pelargoside B1

C30H52O12 (604.3459)

C30H52O12

C30H52O12 (604.3459)

14beta-hydrogen-(20S,22R)-22,26-epoxy-27-[(beta-glucopyranosyl)oxy]ergosta-2,4,6,24-tetraene-1,26-dione|baimantuoluoside H

C34H52O9 (604.3611)

biselyngbyaside

C34H52O9 (604.3611)

(1R*,3S*,5S*,6aR*,7R*,8R*,9S*,10S*,10aR*)-1,10-bis(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2Z)-3-methylpenta-2,4-dien-1-yl]-3,5,6,6a,7,8,9,10-octahydronaphtho[1,8a-c]furan-3,9-diyl dibutanoate

C33H48O10 (604.3247)

(21alpha-H)-24-norneohopa-4(23),22(29)-diene-3beta,6beta,7beta-triol 7-caffeate

C38H52O6 (604.3764)

caseamembrin R|rel-(2S,5R,6S,7R,8S,9S,10R,18S,19R)-2-(2-methylbutanoyloxy)-18-butanoyloxy-7,19-diacetoxy-18,19-epoxy-6,7-dihydroxy-cleroda-3,13(16),14-triene

C33H48O10 (604.3247)

stemphone F

C33H48O10 (604.3247)

11beta-Alcohol, Me ester-Viridominic acid A

C34H52O9 (604.3611)

physagulin

C34H52O9 (604.3611)

Casearin N

C33H48O10 (604.3247)

C30H53BrO7

C30H53BrO7 (604.2974)

aplysioviolin

C34H44N4O6 (604.3261)

cryptophycin 4|Cryptophycin D|cryptophycin-4

C35H44N2O7 (604.3148)

(5alpha,7alpha,13alpha,17alpha,20S,23R,24R)-21,24-epoxy-23,25-dihydroxy-4,8,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol B

C38H52O6 (604.3764)

Lys Asn Lys Glu Ser

C24H44N8O10 (604.318)

Gly Leu Arg Val Phe

C29H48N8O6 (604.3697)

Ile Thr Ser Arg Glu

C24H44N8O10 (604.318)

Arg Thr Leu Ser Asp

C24H44N8O10 (604.318)

Ile Val Ile Phe Asn

C30H48N6O7 (604.3584)

Glu Ile Asp Thr Lys

C25H44N6O11 (604.3068)

C33H48O10_(2alpha,5alpha,9alpha,10beta,14beta)-2,5,9,10-Tetraacetoxytaxa-4(20),11-dien-14-yl 2-methylbutanoate

C33H48O10 (604.3247)

Phe Pro Arg Trp

C31H40N8O5 (604.3122)

Phe Pro Trp Arg

C31H40N8O5 (604.3122)

Phe Arg Pro Trp

C31H40N8O5 (604.3122)

Phe Arg Trp Pro

C31H40N8O5 (604.3122)

Phe Trp Pro Arg

C31H40N8O5 (604.3122)

Phe Trp Arg Pro

C31H40N8O5 (604.3122)

His His Arg Arg

C24H40N14O5 (604.3306)

His Arg His Arg

C24H40N14O5 (604.3306)

His Arg Arg His

C24H40N14O5 (604.3306)

Ile Met Arg Trp

C28H44N8O5S (604.3155)

Ile Met Trp Arg

C28H44N8O5S (604.3155)

Ile Arg Met Trp

C28H44N8O5S (604.3155)

Ile Arg Trp Met

C28H44N8O5S (604.3155)

Ile Thr Trp Trp

C32H40N6O6 (604.3009)

Ile Trp Met Arg

C28H44N8O5S (604.3155)

Ile Trp Arg Met

C28H44N8O5S (604.3155)

Ile Trp Thr Trp

C32H40N6O6 (604.3009)

Ile Trp Trp Thr

C32H40N6O6 (604.3009)

Leu Met Arg Trp

C28H44N8O5S (604.3155)

Leu Met Trp Arg

C28H44N8O5S (604.3155)

Leu Arg Met Trp

C28H44N8O5S (604.3155)

Leu Arg Trp Met

C28H44N8O5S (604.3155)

Leu Thr Trp Trp

C32H40N6O6 (604.3009)

Leu Trp Met Arg

C28H44N8O5S (604.3155)

Leu Trp Arg Met

C28H44N8O5S (604.3155)

Leu Trp Thr Trp

C32H40N6O6 (604.3009)

Leu Trp Trp Thr

C32H40N6O6 (604.3009)

Met Ile Arg Trp

C28H44N8O5S (604.3155)

Met Ile Trp Arg

C28H44N8O5S (604.3155)

Met Leu Arg Trp

C28H44N8O5S (604.3155)

Met Leu Trp Arg

C28H44N8O5S (604.3155)

Met Arg Ile Trp

C28H44N8O5S (604.3155)

Met Arg Leu Trp

C28H44N8O5S (604.3155)

Met Arg Trp Ile

C28H44N8O5S (604.3155)

Met Arg Trp Leu

C28H44N8O5S (604.3155)

Met Trp Ile Arg

C28H44N8O5S (604.3155)

Met Trp Leu Arg

C28H44N8O5S (604.3155)

Met Trp Arg Ile

C28H44N8O5S (604.3155)

Met Trp Arg Leu

C28H44N8O5S (604.3155)

Pro Phe Arg Trp

C31H40N8O5 (604.3122)

Pro Phe Trp Arg

C31H40N8O5 (604.3122)

Pro Arg Phe Trp

C31H40N8O5 (604.3122)

Pro Arg Trp Phe

C31H40N8O5 (604.3122)

Pro Trp Phe Arg

C31H40N8O5 (604.3122)

Pro Trp Arg Phe

C31H40N8O5 (604.3122)

Arg Phe Pro Trp

C31H40N8O5 (604.3122)

Arg Phe Trp Pro

C31H40N8O5 (604.3122)

Arg His His Arg

C24H40N14O5 (604.3306)

Arg His Arg His

C24H40N14O5 (604.3306)

Arg Ile Met Trp

C28H44N8O5S (604.3155)

Arg Ile Trp Met

C28H44N8O5S (604.3155)

Arg Leu Met Trp

C28H44N8O5S (604.3155)

Arg Leu Trp Met

C28H44N8O5S (604.3155)

Arg Met Ile Trp

C28H44N8O5S (604.3155)

Arg Met Leu Trp

C28H44N8O5S (604.3155)

Arg Met Trp Ile

C28H44N8O5S (604.3155)

Arg Met Trp Leu

C28H44N8O5S (604.3155)

Arg Pro Phe Trp

C31H40N8O5 (604.3122)

Arg Pro Trp Phe

C31H40N8O5 (604.3122)

Arg Arg His His

C24H40N14O5 (604.3306)

Arg Trp Phe Pro

C31H40N8O5 (604.3122)

Arg Trp Ile Met

C28H44N8O5S (604.3155)

Arg Trp Leu Met

C28H44N8O5S (604.3155)

Arg Trp Met Ile

C28H44N8O5S (604.3155)

Arg Trp Met Leu

C28H44N8O5S (604.3155)

Arg Trp Pro Phe

C31H40N8O5 (604.3122)

Thr Ile Trp Trp

C32H40N6O6 (604.3009)

Thr Leu Trp Trp

C32H40N6O6 (604.3009)

Thr Trp Ile Trp

C32H40N6O6 (604.3009)

Thr Trp Leu Trp

C32H40N6O6 (604.3009)

Thr Trp Trp Ile

C32H40N6O6 (604.3009)

Thr Trp Trp Leu

C32H40N6O6 (604.3009)

Trp Phe Pro Arg

C31H40N8O5 (604.3122)

Trp Phe Arg Pro

C31H40N8O5 (604.3122)

Trp Ile Met Arg

C28H44N8O5S (604.3155)

Trp Ile Arg Met

C28H44N8O5S (604.3155)

Trp Ile Thr Trp

C32H40N6O6 (604.3009)

Trp Ile Trp Thr

C32H40N6O6 (604.3009)

Trp Leu Met Arg

C28H44N8O5S (604.3155)

Trp Leu Arg Met

C28H44N8O5S (604.3155)

Trp Leu Thr Trp

C32H40N6O6 (604.3009)

Trp Leu Trp Thr

C32H40N6O6 (604.3009)

Trp Met Ile Arg

C28H44N8O5S (604.3155)

Trp Met Leu Arg

C28H44N8O5S (604.3155)

Trp Met Arg Ile

C28H44N8O5S (604.3155)

Trp Met Arg Leu

C28H44N8O5S (604.3155)

Trp Pro Phe Arg

C31H40N8O5 (604.3122)

Trp Pro Arg Phe

C31H40N8O5 (604.3122)

Trp Arg Phe Pro

C31H40N8O5 (604.3122)

Trp Arg Ile Met

C28H44N8O5S (604.3155)

Trp Arg Leu Met

C28H44N8O5S (604.3155)

Trp Arg Met Ile

C28H44N8O5S (604.3155)

Trp Arg Met Leu

C28H44N8O5S (604.3155)

Trp Arg Pro Phe

C31H40N8O5 (604.3122)

Trp Thr Ile Trp

C32H40N6O6 (604.3009)

Trp Thr Leu Trp

C32H40N6O6 (604.3009)

Trp Thr Trp Ile

C32H40N6O6 (604.3009)

Trp Thr Trp Leu

C32H40N6O6 (604.3009)

Trp Trp Ile Thr

C32H40N6O6 (604.3009)

Trp Trp Leu Thr

C32H40N6O6 (604.3009)

Trp Trp Thr Ile

C32H40N6O6 (604.3009)

Trp Trp Thr Leu

C32H40N6O6 (604.3009)

EIDTK

C25H44N6O11 (604.3068)

IVIFN

C30H48N6O7 (604.3584)

ESLEK

C25H44N6O11 (604.3068)

KNKES

C24H44N8O10 (604.318)

KLTDE

C25H44N6O11 (604.3068)

ITSRE

C24H44N8O10 (604.318)

OKODiA-PA

C29H49O11P (604.3012)

6-O-Linoleylsucrose

C30H52O12 (604.3459)

Telinavir

C33H44N6O5 (604.3373)

C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

(E)-5-hydroxy-2,2,6,6-tetramethylhept-4-en-3-one,manganese

C33H57MnO6 (604.3535)

2,7-Dihydroxy-3,6,10,11-tetrakis(pentyloxy)triphenylene

C38H52O6 (604.3764)

2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-bis[2,4-bis(1,1-dimethylethyl)phenoxy]-

C33H50O6P2 (604.3082)

butane-1,4-diol,hexanedioic acid,hexane-1,6-diol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene

C31H44N2O10 (604.2996)

17-Keto Fulvestrant

C32H45F5O3S (604.3009)

Spinosyn D 17-pseudoaglycone

C34H52O9 (604.3611)

N,N-Bis[4-(diethylamino)phenyl]-N,N-diethyl-1,4-benzenediamine hexafluorophosphate

C30H42N4.HPF6 (604.3129)

FR 139317

C33H44N6O5 (604.3373)

N~1~-{4-[(tert-Butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinoline-2-carbonyl)aspartamide

C33H44N6O5 (604.3373)

Withalongolide M

C33H48O10 (604.3247)

A steroid saponin that is the monosaccharide derivative of the 19-norwithanolide. It has been isolated from the aerial parts of Physalis longifolia.

Withalongolide N

C33H48O10 (604.3247)

A steroid saponin that is the monosaccharide derivative of the 19-norwithanolide. It has been isolated from the aerial parts of Physalis longifolia.

Dilazep

C31H44N2O10 (604.2996)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

[(1S,2R,3R,4S,5R)-5-azaniumyl-3-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-[(2S,3R,5S,6R)-3-azaniumyl-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxycyclohexyl]azanium

C23H50N5O13+5 (604.3405)

PA(10:0/18:1(12Z)-O(9S,10R))

C31H57O9P (604.374)

PA(18:1(12Z)-O(9S,10R)/10:0)

C31H57O9P (604.374)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C31H57O9P (604.374)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C31H57O9P (604.374)

2-[[(2R)-3-acetyloxy-2-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO9P+ (604.3614)

2-[[(2R)-2-acetyloxy-3-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO9P+ (604.3614)

2-[[2-[[2-[[1-Azepanyl(oxo)methyl]amino]-4-methyl-1-oxopentyl]amino]-3-(1-methyl-3-indolyl)-1-oxopropyl]amino]-3-(2-pyridinyl)propanoic acid

C33H44N6O5 (604.3373)

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-cyclohexyl-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea

C32H43F3N4O4 (604.3236)

[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14-trienyl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

C31H57O9P (604.374)

(4S,5E,9E,11S,13E,15E,18R)-4-[(2R,3R,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-8-methoxy-9,11-dimethyl-18-[(1Z,4E)-2-methylhexa-1,4-dienyl]-1-oxacyclooctadeca-5,9,13,15-tetraen-2-one

C34H52O9 (604.3611)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C30H53O10P (604.3376)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C30H53O10P (604.3376)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C30H53O10P (604.3376)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C30H53O10P (604.3376)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C30H53O10P (604.3376)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C30H53O10P (604.3376)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C30H53O10P (604.3376)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C30H53O10P (604.3376)

[1-phosphonooxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C33H49O8P (604.3165)

MGDG O-25:7

C34H52O9 (604.3611)

MGMG 25:7

C34H52O9 (604.3611)

DGGA 21:1;O

C30H52O12 (604.3459)

DGGA 22:0

C31H56O11 (604.3822)

PA O-16:0/12:3;O2

C31H57O9P (604.374)

PA O-20:0/8:3;O2

C31H57O9P (604.374)

PA O-27:4;O3

C30H53O10P (604.3376)

PA O-28:3;O2

C31H57O9P (604.374)

PA P-16:0/11:3;O3

C30H53O10P (604.3376)

PA P-16:0/12:2;O2

C31H57O9P (604.374)

PA P-20:0/7:3;O3

C30H53O10P (604.3376)

PA P-20:0/8:2;O2

C31H57O9P (604.374)

PA P-20:1/7:2;O3

C30H53O10P (604.3376)

PA P-20:1/8:1;O2

C31H57O9P (604.374)

PA 14:0/13:3;O2

C30H53O10P (604.3376)

PA 14:1/12:3;O3

C29H49O11P (604.3012)

PA 18:1/8:3;O3

C29H49O11P (604.3012)

PA 18:2/8:2;O3

C29H49O11P (604.3012)

PA 18:2/9:1;O2

C30H53O10P (604.3376)

PA 20:0/7:3;O2

C30H53O10P (604.3376)

PA 20:1/7:2;O2

C30H53O10P (604.3376)

PA 20:1/8:1;O

C31H57O9P (604.374)

PA 22:0/6:2;O

C31H57O9P (604.374)

PA 22:2/5:1;O2

C30H53O10P (604.3376)

PA 27:3;O2

C30H53O10P (604.3376)

PA 28:2;O

C31H57O9P (604.374)

LPGP O-20:1

C26H54O11P2 (604.3141)

LPGP P-20:0

C26H54O11P2 (604.3141)

PG O-23:5;O2

C29H49O11P (604.3012)

PG O-24:4;O

C30H53O10P (604.3376)

PG P-16:0/8:3;O

C30H53O10P (604.3376)

PG P-16:1/7:3;O2

C29H49O11P (604.3012)

PG P-18:1/6:2;O

C30H53O10P (604.3376)

PG 16:1/7:3;O

C29H49O11P (604.3012)

PG 18:3/5:1;O

C29H49O11P (604.3012)

PG 23:4;O

C29H49O11P (604.3012)

PG 2:0_22:3

C30H53O10P (604.3376)

PG 20:2/4:1

C30H53O10P (604.3376)

PG 20:3/4:0

C30H53O10P (604.3376)

PG 24:3

C30H53O10P (604.3376)

PEth 26:2;O

C31H57O9P (604.374)

PEth 28:8

C33H49O8P (604.3165)

PM 27:2;O

C31H57O9P (604.374)

PM 29:8

C33H49O8P (604.3165)

ST 23:0;O7;GlcA

C29H48O13 (604.3095)

ST 27:4;O4;GlcA

C33H48O10 (604.3247)

ST 28:3;O3;GlcA

C34H52O9 (604.3611)

ST 23:1;O8;Hex

C29H48O13 (604.3095)

ST 24:0;O7;Hex

C30H52O12 (604.3459)

ST 27:5;O5;Hex

C33H48O10 (604.3247)

ST 28:4;O4;Hex

C34H52O9 (604.3611)

Cyclic GMP (TBAOH)

C26H49N6O8P (604.3349)

Cyclic GMP TBAOH is a tetra-n-butylammonium hydroxide (TBAOH) form of Cyclic GMP (HY-12512). Cyclic GMP is an endogenous second messenger that regulates a variety of cellular processes including apoptosis, vasodilation, and neurotransmission through the activation of signaling pathways such as Protein Kinase G in cells[1].

(3s,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,13ar,13bs)-7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C38H52O6 (604.3764)

3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-(2-isopropyl-5-methylhex-4-en-1-yl)-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H52O6 (604.3764)

1-[2-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-(4-hydroxyphenyl)-n-methylpropanamido)-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C32H52N4O7 (604.3836)

2-[2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)

2-[(4as,5r,8ar)-5-{[(1r,3s,4as,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-1-hydroxy-2-methoxy-6-methyl-4-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl]-5,7-dihydroxychromen-4-one

C36H44O8 (604.3036)

(1s,3s,3ar,5s,6r,7s,7ar)-1-[(1r)-1-(acetyloxy)ethyl]-3,6-bis({[(2s)-2-methylbutanoyl]oxy})-4-methylidene-7-[(2s)-2-methyloxiran-2-yl]-2-oxo-hexahydro-1h-inden-5-yl (2e)-3-methylpent-2-enoate

C33H48O10 (604.3247)

3-heptyl-5-hydroxyphenyl 2-{[(2s,3r,4r)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}-6-heptyl-4-hydroxybenzoate

C33H48O10 (604.3247)

(1r,4s)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C30H53BrO7 (604.2974)

2α-(α-methylbutyryl)-oxy-5α,7β,9α,10β-tetra-acetoxy-4(20),11-taxadiene

C33H48O10 (604.3247)

{"Ingredient_id": "HBIN005275","Ingredient_name": "2\u03b1-(\u03b1-methylbutyryl)-oxy-5\u03b1,7\u03b2,9\u03b1,10\u03b2-tetra-acetoxy-4(20),11-taxadiene","Alias": "NA","Ingredient_formula": "C33H48O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14191","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3beta-p-hydroxybenzoyldehydrotumtlosic acid

C38H52O6 (604.3764)

{"Ingredient_id": "HBIN008331","Ingredient_name": "3beta-p-hydroxybenzoyldehydrotumtlosic acid","Alias": "NA","Ingredient_formula": "C38H52O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C5=CC=C(C=C5)O)C)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3β-p-hydroxybenzoyldehydrotumulosicacid

C38H52O6 (604.3764)

{"Ingredient_id": "HBIN008332","Ingredient_name": "3\u03b2-p-hydroxybenzoyldehydrotumulosicacid","Alias": "NA","Ingredient_formula": "C38H52O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C5=CC=C(C=C5)O)C)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15813","TCMID_id": "9822","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2r,6r)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

(2r,6r)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

(3r,6r)-6-[(2s,5r)-5-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-5-methyloxolan-2-yl]-2-methylheptane-2,3,6-triol

C30H53BrO7 (604.2974)

(1s,2r,8r,10r,11r,15s,16s,18r)-15-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-10-hydroxy-2,7,7,16-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-18-yl (2r)-2-methylbutanoate

C34H52O9 (604.3611)

15-(acetyloxy)-10-hydroxy-5-(methoxycarbonyl)-5,9-dimethyl-2-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-8-yl 2,3-dimethyloxirane-2-carboxylate

C33H48O10 (604.3247)

(3s,6r)-6-[(2s,5r)-5-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-5-methyloxolan-2-yl]-2-methylheptane-2,3,6-triol

C30H53BrO7 (604.2974)

(3r,3as,5ar,5br,6r,7s,7ar,9s,11as,11br,12r,13ar,13bs)-12-(acetyloxy)-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)

(1s,2s,3r,8s,10s,11s,15r,16r)-3-(acetyloxy)-15-[(3r,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-[(2s)-2-isopropyl-5-methylhex-4-en-1-yl]-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H52O6 (604.3764)

5,7-dihydroxy-2-{1-hydroxy-5-[(3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-2-methoxy-6-methyl-4-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl}chromen-4-one

C36H44O8 (604.3036)

(2s,3s,4s,5r,6r)-4-{[(2s,3r,4r,5s,6s)-3,4-bis(acetyloxy)-5-hydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-2-methyl-6-(octyloxy)oxan-3-yl hexanoate

C30H52O12 (604.3459)

(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2r,3r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

(2s)-1-[(2s)-2-[(2r)-2-{[(2s,3s)-1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-(4-hydroxyphenyl)-n-methylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C32H52N4O7 (604.3836)

4-[6-(5-bromo-2,6,6-trimethyloxan-2-yl)-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C30H53BrO7 (604.2974)

(2s)-n-[(2s)-1-[(2s)-2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-[(2s)-2-(dimethylamino)-n,3-dimethylbutanamido]-n,3-dimethylbutanamide

C35H48N4O5 (604.3625)

(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2s,3s)-2-{[(2s)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-15-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(3s,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)

(3r,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,12s,13ar,13bs)-7-(acetyloxy)-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)

3-(acetyloxy)-15-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

3-[(2r)-2-[(5-{[(2r)-4-ethenyl-5-hydroxy-3-methyl-2h-pyrrol-2-yl]methyl}-3-(3-methoxy-3-oxopropyl)-4-methyl-1h-pyrrol-2-yl)methyl]-5-{[(2r,3e,4s)-3-ethylidene-5-hydroxy-4-methyl-2,4-dihydropyrrol-2-yl]methyl}-4-methyl-2h-pyrrol-3-yl]propanoic acid

C34H44N4O6 (604.3261)

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)

6-[(2s,5r)-5-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-5-methyloxolan-2-yl]-2-methylheptane-2,3,6-triol

C30H53BrO7 (604.2974)

(2r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1r)-1-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-3,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-1-yl butanoate

C33H48O10 (604.3247)

(2s)-1-[(2s)-2-[(2s)-2-{[(2r,3r)-1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-(4-hydroxyphenyl)-n-methylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C32H52N4O7 (604.3836)

3-[2-({5-[(4-ethenyl-5-hydroxy-3-methyl-2h-pyrrol-2-yl)methyl]-3-(3-methoxy-3-oxopropyl)-4-methyl-1h-pyrrol-2-yl}methyl)-5-[(3-ethylidene-5-hydroxy-4-methyl-2,4-dihydropyrrol-2-yl)methyl]-4-methyl-2h-pyrrol-3-yl]propanoic acid

C34H44N4O6 (604.3261)

(3s)-3-[(2s,3r)-3-(acetyloxy)-1-[(2s)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]-3-{[(2s)-2-({1-hydroxy-2-[(1-hydroxy-2-methylpropylidene)amino]ethylidene}amino)-3-phenylpropanoyl]oxy}propanoic acid

C30H44N4O9 (604.3108)

(1s,2s,3r,5s,8r,9r,10r,14s)-2,5,9,10-tetrakis(acetyloxy)-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-14-yl 2-methylbutanoate

C33H48O10 (604.3247)

1-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)

2-[(7s,9as,11ar)-2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)

3-heptyl-5-hydroxyphenyl 2-heptyl-4-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

C33H48O10 (604.3247)

(1r,3r,5r,6as,7s,8s,9r,10r,10as)-3,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-1-yl butanoate

C33H48O10 (604.3247)

(1s,2s,3r,8s,10s,11s,15r,16r)-3-(acetyloxy)-15-[(3r,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

(2s,3s,4s,5r,6r)-4-{[(2s,3r,4r,5r,6s)-3,5-bis(acetyloxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-2-methyl-6-(octyloxy)oxan-3-yl hexanoate

C30H52O12 (604.3459)

n-(1-{[1-(2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl)-1-oxo-3-phenylpropan-2-yl](methyl)carbamoyl}-2-methylpropyl)-2-(dimethylamino)-n,3-dimethylbutanamide

C35H48N4O5 (604.3625)

n-(5-carbamimidamido-1-hydroxypentan-2-yl)-1-[(2s)-2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

1,9-bis(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 2-methylbutanoate

C33H48O10 (604.3247)

3,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-1-yl butanoate

C33H48O10 (604.3247)

3-heptyl-5-hydroxyphenyl 2-{[(2s,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}-6-heptyl-4-hydroxybenzoate

C33H48O10 (604.3247)

(4as,6ar,6br,10s,12ar,14bs)-6a-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C38H52O6 (604.3764)

(1r,2s,4s,5r,8r,9s,10r,13r,15r)-15-(acetyloxy)-10-hydroxy-5-(methoxycarbonyl)-5,9-dimethyl-2-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-8-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate

C33H48O10 (604.3247)

1,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C33H48O10 (604.3247)

(1s,4s)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C30H53BrO7 (604.2974)

3-heptyl-5-hydroxyphenyl 2-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-6-heptyl-4-hydroxybenzoate

C33H48O10 (604.3247)

7-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-6-hydroxy-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one

C33H48O10 (604.3247)

2-[(1s,4as,5s,8ar)-5-{[(1r,3s,4as,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-1-hydroxy-2-methoxy-6-methyl-4-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl]-5,7-dihydroxychromen-4-one

C36H44O8 (604.3036)

6-{5-[6-(5-bromo-2,6,6-trimethyloxan-2-yl)-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-5-methyloxolan-2-yl}-2-methylheptane-2,3,6-triol

C30H53BrO7 (604.2974)

(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

n-(5-carbamimidamido-1-hydroxypentan-2-yl)-1-(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl)-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

4,8,15,19,26,30-hexahydroxy-1,12-dioxa-4,9,15,20,26,31-hexaazacyclotritriaconta-8,19,30-triene-5,16,27-trione

C25H44N6O11 (604.3068)

7-(acetyloxy)-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-15-[(3s,5s,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

(1r,3s,5s,6ar,7r,8r,9r,10s,10ar)-1,9-bis(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 2-methylbutanoate

C33H48O10 (604.3247)

(1r,3r,5r,6as,7s,8s,9r,10r,10as)-1,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C33H48O10 (604.3247)

(1r,3s,5s,6ar,7s,8r,9r,10s,10as)-1,9-bis(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2r)-2-methylbutanoate

C33H48O10 (604.3247)

(1r,3s,5s,6ar,7r,8r,9r,10s,10ar)-1,9-bis(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2r)-2-methylbutanoate

C33H48O10 (604.3247)

(3r,4r,5s,6r)-6-{[(4e,6e,10e,14z,16e)-2,9-diethyl-12-hydroxy-5,7,11,17-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl]oxy}-4,5-dihydroxy-2,2-dimethyloxan-3-yl acetate

C34H52O9 (604.3611)

9,12-dihydroxy-10-[(4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-(4-phenylbut-3-en-2-yl)-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C35H44N2O7 (604.3148)

(1r,4s)-4-[(4as,6s,8ar)-6-[(2r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C30H53BrO7 (604.2974)

(1s,4r)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C30H53BrO7 (604.2974)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C33H48O10 (604.3247)

1-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)

(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2s)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C38H52O6 (604.3764)

3-(acetyloxy)-15-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

6-[1-(9-hydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H52O9 (604.3611)

(3r,6r)-6-[(2r,2's,5s,5's)-5'-[(2r,4as,7r,9ar)-7-bromo-2,6,6,9a-tetramethyl-hexahydropyrano[3,2-b]oxepin-2-yl]-2-methyl-[2,2'-bioxolan]-5-yl]-2-methylheptane-2,3,6-triol

C30H53BrO7 (604.2974)

(1r,4r)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C30H53BrO7 (604.2974)

(2s,4as,6as,6br,8ar,10r,12ar,12br,14br)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2,6a,6b,9,9,12a-hexamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-2-carboxylic acid

C38H52O6 (604.3764)

(2r,4as,4br,6r,7r,10ar)-7-{[(2s,4s,5r,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-6-hydroxy-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one

C33H48O10 (604.3247)

(2r,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2s)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

2-(5-{[(1r,3s,4as,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-1-hydroxy-2-methoxy-6-methyl-4-oxo-1,5,8,8a-tetrahydronaphthalen-4a-yl)-5,7-dihydroxychromen-4-one

C36H44O8 (604.3036)

(2r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

3-heptyl-5-hydroxyphenyl 2-heptyl-4-hydroxy-6-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

C33H48O10 (604.3247)

(1r,4s)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C30H53BrO7 (604.2974)

12-(acetyloxy)-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)

2-[(1-{1-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]ethyl}-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl)oxy]-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

(3s,6r,10r,13e,16s)-9,12-dihydroxy-10-[(4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-[(2r,3e)-4-phenylbut-3-en-2-yl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C35H44N2O7 (604.3148)

(6r)-6-[(1s)-1-[(1r,3as,3bs,7r,9s,9ar,9bs,11as)-9-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H52O9 (604.3611)